← Back
Data updated: Mar 10, 2026
XIAMEN LP PHARM CO
Neurology
XIAMEN LP PHARM CO is a generic drug manufacturer focused on Neurology. Key products include OPIPZA.
2017
Since
6
Drugs
-
Trials
71
Approved (2yr)
Key Drugs
Recent Activity
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-01-27
Labeling
TOPIRAMATE 2026-01-18
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (2)
Company Info
- First Approval
- 2017-11-20
- Latest
- 2025-08-06
- Applications
- 6